Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.

Le Houézec D.

Immunol Res. 2014 Dec;60(2-3):219-25. doi: 10.1007/s12026-014-8574-4.

2.

Is there a causal link between hepatitis B vaccination and multiple sclerosis?

Monteyne P, André FE.

Vaccine. 2000 Apr 3;18(19):1994-2001.

PMID:
10706960
3.

Hepatitis B virus (HBV) infection and multiple sclerosis: One more reason to undergo vaccination?

Mormile R.

Immunol Lett. 2015 May;165(1):60-1. doi: 10.1016/j.imlet.2015.03.004. Epub 2015 Mar 17. No abstract available.

PMID:
25794632
4.

Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.

Tosti ME, Traversa G, Bianco E, Mele A.

Ital J Gastroenterol Hepatol. 1999 Jun-Jul;31(5):388-91.

PMID:
10470598
5.

Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.

Spira A, Bégué P, Aurengo A.

Immunol Res. 2015 May;62(1):1-2. doi: 10.1007/s12026-015-8627-3. No abstract available.

PMID:
25690885
6.

Hepatitis B vaccine and risk of multiple sclerosis.

DeStefano F, Verstraeten T, Chen RT.

Expert Rev Vaccines. 2002 Dec;1(4):461-6. Review.

PMID:
12901584
7.

A new French paradox: HBV vaccination.

Braillon A.

J Hepatol. 2009 Sep;51(3):597-8; author reply 598-9. doi: 10.1016/j.jhep.2009.05.009. Epub 2009 May 27. No abstract available.

8.

Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis.

Mikaeloff Y, Caridade G, Rossier M, Suissa S, Tardieu M.

Arch Pediatr Adolesc Med. 2007 Dec;161(12):1176-82.

PMID:
18056563
9.

[French specificities in the history of vaccination. The end of an exception?].

Moulin AM.

Rev Epidemiol Sante Publique. 2006 Jul;54 Spec No 1:1S81-1S87. French.

PMID:
17073134
10.

[Persistence of immunity after hepatitis B vaccination].

Madaliński K.

Przegl Epidemiol. 2002;56(4):605-13. Review. Polish.

PMID:
12666586
12.

Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review.

Demicheli V, Rivetti A, Di Pietrantonj C, Clements CJ, Jefferson T.

J Viral Hepat. 2003 Sep;10(5):343-4. Review. No abstract available.

PMID:
12969184
13.

[Hepatitis B vaccination. Advocating for a protection principle].

Aron E.

Bull Acad Natl Med. 2002;186(2):361-6; discussion 366-8. French.

PMID:
12145843
14.

Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.

Scognamiglio P, Girardi E, Fusco M, Piselli P, Spena SR, Maione C, Pisanti FA, Serraino D; Collaborating Study Group.

BMC Infect Dis. 2009 Jun 7;9:86. doi: 10.1186/1471-2334-9-86.

15.
16.

[Vaccination against hepatitis B. Many more advantages than disadvantages].

Erlinger S.

Presse Med. 1997 Feb 1;26(2):60-1. French.

PMID:
9082410
17.

[Pharmacovigilance of hepatitis B vaccines].

Imbs JL, Decker N, Welsch M.

Bull Acad Natl Med. 2003;187(8):1489-98; discussion 1498-500. French.

PMID:
15146580
18.

[Vaccination against hepatitis B and the risk of multiple sclerosis].

Magdzik W, Zieliński A.

Przegl Epidemiol. 2005;59(1):11-9. Review. Polish.

PMID:
16013405
19.

Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.

MacIntyre CR, Kelly H, Jolley D, Butzkueven H, Salmon D, Halsey N, Moulton LH.

Neurology. 2005 Apr 12;64(7):1317; author reply 1318. No abstract available.

PMID:
15824381
20.

The march of science.

Rivara FP, Christakis DA.

Arch Pediatr Adolesc Med. 2007 Dec;161(12):1214-5. No abstract available.

PMID:
18056569

Supplemental Content

Support Center